Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responses by S. K. Yang
Yang et al. BMC Medical Genomics 2010, 3:19
http://www.biomedcentral.com/1755-8794/3/19
Open AccessR E S E A R C H  A R T I C L EResearch articleDynamic cross-talk analysis among TNF-R, TLR-4 
and IL-1R signalings in TNFα-induced inflammatory 
responses
Shih-Kuang Yang†1, Yu-Chao Wang†1, Chun-Cheih Chao2, Yung-Jen Chuang2,3, Chung-Yu Lan3,4 and Bor-Sen Chen*1
Abstract
Background: Development in systems biology research has accelerated in recent years, and the reconstructions for 
molecular networks can provide a global view to enable in-depth investigation on numerous system properties in 
biology. However, we still lack a systematic approach to reconstruct the dynamic protein-protein association networks 
at different time stages from high-throughput data to further analyze the possible cross-talks among different 
signaling/regulatory pathways.
Methods: In this study we integrated protein-protein interactions from different databases to construct the rough 
protein-protein association networks (PPANs) during TNFα-induced inflammation. Next, the gene expression profiles of 
TNFα-induced HUVEC and a stochastic dynamic model were used to rebuild the significant PPANs at different time 
stages, reflecting the development and progression of endothelium inflammatory responses. A new cross-talk ranking 
method was used to evaluate the potential core elements in the related signaling pathways of toll-like receptor 4 (TLR-
4) as well as receptors for tumor necrosis factor (TNF-R) and interleukin-1 (IL-1R).
Results: The highly ranked cross-talks which are functionally relevant to the TNFα pathway were identified. A bow-tie 
structure was extracted from these cross-talk pathways, suggesting the robustness of network structure, the 
coordination of signal transduction and feedback control for efficient inflammatory responses to different stimuli. 
Further, several characteristics of signal transduction and feedback control were analyzed.
Conclusions: A systematic approach based on a stochastic dynamic model is proposed to generate insight into the 
underlying defense mechanisms of inflammation via the construction of corresponding signaling networks upon 
specific stimuli. In addition, this systematic approach can be applied to other signaling networks under different 
conditions in different species. The algorithm and method proposed in this study could expedite prospective systems 
biology research when better experimental techniques for protein expression detection and microarray data with 
multiple sampling points become available in the future.
Background
One main interest of molecular biologists is to under-
stand the underlying mechanisms in a cell, including the
synthesis of DNA, RNA and protein and how these mole-
cules are regulated. In the last decade, researchers have
uncovered a multitude of biological facts, such as protein
3D structures and genome sequences and organizations.
However, this information is not sufficient to interpret
the entire biological process and to understand its robust-
ness, which is one of the fundamental properties of living
systems at different cell levels [1]. Thus understanding
how genes, proteins, and small molecules interact to form
the functional modules and robust systems has become
one of the major challenges in systems biology in recent
years. With the advance of experimental techniques,
many researchers have utilized high-throughput data
such as DNA microarray, yeast two-hybrid assay, co-
immunoprecipitation, and ChIP-chip approach to study
the bio-molecular networks. In particular, these kinds of
data are usually integrated to construct various types of
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Page 2 of 19molecular networks including protein-protein interac-
tion networks, gene regulatory networks, metabolic net-
works and gene co-expression networks. These
molecular networks have been demonstrated with great
potentials to discover basic functions and to reveal essen-
tial mechanisms for various biological phenomena, by
understanding biological systems not on an individual
component level but on a system-wide level [2].
One of the extensively investigated biological systems is
the inflammatory system of humans. It orchestrates a
complex biological process, which engages a variety of
cell types that eliminate invading microorganisms to pro-
tect the host [3]. Infected hosts recognize the ligands on
the surface of disease-causing pathogens and mobilize
specific inflammatory defense mechanisms. On the other
hand, pathogens can proactively perturb host defense sig-
naling pathways to enhance their survival [4]. In this case,
the hosts and the pathogens in the inflammatory
responses are considered as two players with conflicts of
interest in the game theory [5]. Therefore, the inflamma-
tory responses are highly context dependent, suggesting
unplumbed complexity, and a wealth of intricate intra-
and inter-cellular interactions [6]. In the human self-pro-
tection mechanism, vascular endothelium plays a central
role in the regulation of several inflammatory functions.
Products from bacteria and viruses that stimulate leuko-
cyte and endothelial release of cytokines, chemokines,
and lipid mediators may also play a role in inflammation.
These stimuli can alter gene regulation of endothelial leu-
kocyte adhesion molecules, cell signal transduction path-
ways, and endothelial permeability. Tumor necrosis
factor (TNF) is one of the important cytokine that has
long been considered as a pathological factor implicated
in the pathology of dozens of human diseases, including
septic shock [7], cancer [8], rheumatoid arthritis [9],
malaria [10] and other afflictions. Two protein families
have been implicated in the signaling pathway mediated
by the receptors for tumor necrosis factor (TNF-R).
These include the death domain-containing proteins
(TNFR1, TRADD, RIP and FADD) and the TRAF
domain-containing proteins (TNFR2, CD40, and TRAF1-
6). Based on current models, upon binding of TNF to
TNFR1, a protein called the silencer of death domain
(SODD) is released and TRADD is recruited. TRADD
then recruits TRAF2, RIP, and FADD, leading to activa-
tion of signaling cascades that mediate c-jun N-terminal
kinase (JNK) activation, nuclear factor kappa-B (NF-κB)
activation, and apoptosis. Binding of TNF to TNFR2
expressed by endothelial cells may lead to cell activation
or apoptosis. Because both responses are initiated by
ligand binding to a single receptor, it is clear that TNF
activates multiple signal transductions [11].
Apart from TNF-Rs, there are two other central signal-
ing pathways mediated by toll-like receptor 4 (TLR-4)
and interleukin-1 receptor (IL-1R) which both play
important roles in inflammation by regulating the activity
of transcription factors such as NF-κB. From TLR-4, IL-
1R and TNF-R signalings to NF-κB, there is a conver-
gence on a common IκB kinase complex that phosphory-
lates the NF-κB inhibitory protein IκBα, namely inhibitor
of nuclear factor kappa-B kinase (IKK) [12,13]. Although
how TNF-R signals on the cell surface activate the IKK
complex is not completely understood, studies have iden-
tified most key signaling components, and uncovered
post-translational modification and cellular transloca-
tion of these components [14]. Previously published stud-
ies have shown that upstream signaling components are
mostly receptor-specific, but the principles of signaling
are similar, involving the recruitment of specific adaptor
proteins and the activation of kinase cascades in which
protein-protein interactions are controlled by poly-ubiq-
uitination [12]. Because they need to cope with a broader
range of pathogens with limited resources, some efficient
signaling structures are reduplicate. Therefore, under-
standing these pathways has been focused on the identifi-
cation of signaling network, the role of cytokine inducer
and the subcellular translocation of those components by
integrating various types of genomic and proteomic data.
Although many works have extracted some characteris-
tics of TNF signaling transductions, however, there is still
lack of a comprehensive approach to discover the system-
atic and dynamic properties of multi-pathway signaling
networks under specific stimulant conditions. The most
common way to construct protein-protein interaction
(PPI) networks in the network studies is to use public
available PPI database, published literatures and experi-
mental data to connect the edges between proteins. How-
ever, most of these reconstructions of the PPI network
merely displayed the static properties of interactions
rather than discussing the dynamic associations and evo-
lution of network topology. Therefore, the basic concept
in this study lies in introducing the time-course gene
expression data to endow the static protein-protein inter-
actions with significantly dynamic changes, which corre-
spond to the real circumstances in the living organism
(see Figure 1). Various types of data were integrated,
including gene expression profiles downloaded from the
Gene Expression Omnibus (GEO) database (http://
www.ncbi.nlm.nih.gov/geo/ accession number:
GSE9055), pathway information from KEGG http://
www.genome.ad.jp/kegg/[15] and NetPath http://
www.netpath.org/[16], PPI information from BioGRID
database http://www.thebiogrid.org/[17], and PPI clues
from STRING http://string-db.org/[18] to infer a rough
protein-protein association network (PPAN). According
to the rough PPAN, a dynamic model was constructed for
a protein to describe its associations with other proteins.
Then, based on microarray expression profiles of differ-
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proteins were further identified by the constrained least
squares parameter estimation method for each time
stage, respectively. The insignificant associations were
pruned and the significant protein-protein associations
were reserved for the specific time stage according to the
identified association coefficients. In this case, the pre-
served association represent the effective PPI for a spe-
cific time stage under a specific stimulus. This procedure
was iterated one protein by one protein, and finally the
whole protein-protein interaction networks were con-
structed for the vascular inflammatory response system
at different time stages, which can be used to investigate
the development of PPI network in the inflammation to
the TNFα stimulus. A new cross-talk ranking method
was also developed to evaluate the potential core ele-
ments in the related signaling pathways. Furthermore, a
bow-tie structure was observed and considered as a core
system mediating the input pathological factors and the
output host responses for efficient processing of a
broader range of pathogens with limited proteins and
pathways, suggesting the robustness of the network.
Methods
Constructing the rough PPANs
The dynamic expression and assembly of all functional
components in the genome of an organism are signifi-
cantly influenced by the environment. In this study, we
aimed at the reconstruction of the protein-protein associ-
ation networks under TNFα stimulus at different time
stages and the analysis of dynamic cross-talks to investi-
gate the network characteristics of an endothelial inflam-
matory system. The proposed method of the PPAN
construction is divided into four steps (see Figure 2). The
rough PPAN responsive to TNFα stress is established in
the first two steps, and the refinement is then performed
in the last two steps.
Step 1
In this step, the proteins of interest were selected to con-
struct the protein pool. We first selected 21 proteins (see
Table 1, column 1) that are associated with the TNFα
stress based on data mining in the published literatures
and known pathway diagrams [12,14-16,19-22]. Then, we
selected 24 proteins which are involved in IL-1 and TLR-
4 (both MyD88-dependant and MyD88-independant)
pathways and might be triggered under the TNFα stimu-
lus (see Table 1, columns 2-4). Finally, we chose 15 nega-
tive regulator proteins [14,23,24] which are considered to
have anti-inflammatory therapeutic potential and/or pos-
sible feedback control signals in human endothelial
inflammatory system (see Table 1, column 5). The total
60 proteins constituted the protein pool in this study and
the protein-protein association networks were con-
structed among these proteins. Further, the Gene Ontol-
ogy annotations for these 60 proteins are shown in
Supplementary Table S1 [Additional file 1].
Step 2
To construct the static protein-protein interaction list for
these 60 proteins, PPI information from BioGRID http://
www.thebiogrid.org/[17] and STRING http://string-
db.org/[18] databases were used. BioGRID (Biological
General Repository for Interaction Datasets) contains
over 198,000 of protein and genetic interactions informa-
tion from six major model organism species [17].
STRING (the Search Tool for the Retrieval of Interacting
Genes/Proteins) is a database of known and predicted
protein interactions, including direct (physical) and indi-
rect (functional) associations; they are derived from four
various genome and high-throughput sources. STRING
currently covers 2,483,276 proteins from 630 organisms
[18]. These two databases were integrated to indicate the
possible association between two proteins, and the rough
PPAN was constructed based on the 60 proteins in the
protein pool and the possible interactions among them.
Pruning the rough PPAN via a dynamic model
On the basis of the database information and the litera-
ture evidences, the rough PPAN, which consists of all
possible static interactions among the proteins of inter-
est, was constructed. Since the rough PPAN only outlined
the possible protein interactions under all kinds of exper-
imental conditions, these interactions were further
pruned to indicate the effective protein interactions
under TNFα stress. As the time profiles of microarrays
Figure 1 Schematic diagram for reconstructing the protein-pro-
tein association. This diagram shows the basic concept of the recon-
struction of protein-protein association. On the protein level, the 
interactions between proteins from the well-known database and ex-
perimental data were extracted. However, this kind of interactions only 
reflects all possible static connections without stimulus-specific re-
sponse or temporal changes. Our model includes the gene expression 
patterns from different time course to infer the dynamic protein-pro-
tein associations and networks, suggesting a more significant and re-
alistic method for network reconstruction of the living organism.
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Figure 2 Flowchart of the proposed method to construct the protein-protein association network (PPAN). This flowchart depicts the process 
to construct the protein-protein association network (PPAN) and the afterward investigations in this study. The four key steps of PPAN construction 
are described in details in the text. The rough PPAN is set up from steps (1) and (2), and the refinement is then performed in steps (3) and (4) to obtain 
the refined PPAN.
Proliferation Apoptosis p38 MAPK NFkB
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Table 1: Human protein candidates and their pathway catalogues in this study.
TNF IL-1 MyD88-dependent 
TLR-4
MyD88-independent 
TLR-4
Negative regulators
TNF IL1α MyD88 TLR4 A20
TNFR1 IL1β TIRAP TRAM CYLD
TNFR2 IL1R1 CD14 TRIF FLN29
TRADD IL1R2 PELI2 TRAF3 IRAK3
FADD TOLLIP IRAK4 TANK NOD2
GRB2 ST2L IRAK1 TBK1 RIP3
SOS1 PELI1 NIK IKKε PTPN11
CAV1 ECSIT BCL10 IRF3 RNF216
CASP8 SARM
TRAF2 SIGIRR
TRAF5 SOCS1
TTRAP TMED1
TRAF6 TNIP3
RIP TRAF4
MEKK3 UBE2N
TAK1
TAB1
TAB2
IKKα
IKKβ
IKKγ
Proteins in the cross-talk analysis are classified into three major pathways, including TNFα, IL-1, TLR-4 (for both MyD88-dependent and 
MyD88-independent) pathways. The full names of these proteins are listed in the following. BCL10: B-cell CLL/lymphoma 10, NOD2: 
nucleotide-binding oligomerization domain containing 2, CASP8: caspase 8, apoptosis-related cysteine peptidase, CAV1: caveolin 1, caveolae 
protein, 22 kDa, CD14: CD14 molecule, IKKα: conserved helix-loop-helix ubiquitous kinase, CYLD: cylindromatosis (turban tumor syndrome), 
FADD: Fas (TNFRSF6)-associated via death domain, GRB2: growth factor receptor-bound protein 2, IKKβ: inhibitor of kappa light polypeptide 
gene enhancer in B-cells, kinase beta, IKKε: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon, IKKγ: inhibitor of 
kappa light polypeptide gene enhancer in B-cells, kinase gamma, IL1α: interleukin 1, alpha, IL1β: interleukin 1, beta, IL1R1: interleukin 1 
receptor, type I, IL1R2: interleukin 1 receptor, type II, ST2L: interleukin 1 receptor-like 1, IRAK1: interleukin-1 receptor-associated kinase 1, 
IRAK3: Interleukin-1 receptor-associated kinase 3, IRAK4: interleukin-1 receptor-associated kinase 4, IRF3: interferon regulatory factor 3, NIK: 
mitogen-activated protein kinase kinase kinase 14, MEKK3: mitogen-activated protein kinase kinase kinase 3, TAK1: Mitogen-activated 
protein kinase kinase kinase 7, TAB1: mitogen-activated protein kinase kinase kinase 7 interacting protein 1, TAB2: mitogen-activated protein 
kinase kinase kinase 7 interacting protein 2, MyD88: myeloid differentiation primary response gene (88), PELI1: pellino homolog 1 
(Drosophila), PELI2: pellino homolog 2 (Drosophila), PTPN11: protein tyrosine phosphatase, non-receptor type 11 (Noonan syndrome 1), RIP: 
receptor (TNFRSF)-interacting serine-threonine kinase 1, RIP3: receptor-interacting serine-threonine kinase 3, SARM: sterile alpha and TIR 
motif containing 1, SIGIRR: single immunoglobulin and toll-interleukin 1 receptor (TIR) domain, ECSIT: ECSIT homolog (Drosophila), SOCS1: 
suppressor of cytokine signaling 1, SOS1: Son of sevenless homolog 1 (Drosophila), TANK: TRAF family member-associated NFKB activator, 
TBK1: TANK-binding kinase 1, TIRAP: toll-interleukin 1 receptor (TIR) domain containing adaptor protein, TLR4: toll-like receptor 4, TMED1: 
transmembrane emp24 protein transport domain containing 1, TNF: tumor necrosis factor (TNF superfamily, member 2), A20: tumor necrosis 
factor, alpha-induced protein 3, TNFR1: tumor necrosis factor receptor superfamily, member 1A, TNFR2: tumor necrosis factor receptor 
superfamily, member 1B, TNIP3: TNFAIP3 interacting protein 3, TOLLIP: toll interacting protein, TRADD: TNFRSF1A-associated via death 
domain, TRAF2: TNF receptor-associated factor 2, TRAF3: TNF receptor-associated factor 3, TRAF4: TNF receptor-associated factor 4, TRAF5: 
TNF receptor-associated factor 5, TRAF6: TNF receptor-associated factor 6, FLN29: TRAF-type zinc finger domain containing 1, TRAM: toll-like 
receptor adaptor molecule 2, RNF216: TRIAD3 protein, TRIF: toll-like receptor adaptor molecule 1, TTRAP: TRAF and TNF receptor associated 
protein, UBE2N: ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast)
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time-course microarray data were employed to assess the
significance of protein-protein interactions at certain
time. Here, a dynamic regulatory model and model selec-
tion method Akaike Information Criterion (AIC) [25]
were used to prune the rough PPAN. The details of the
pruning process are described in the following paragraph
and in Supplementary Methods [Additional file 2].
Step 3
In this step, the protein association equation was used to
describe the protein-protein associations between target
proteins of interest and its possible interacting proteins of
the human inflammatory system. For a target protein p in
the rough PPAN, the stochastic dynamic model of the
protein is as follows [26]
where yp[t] represents the protein expression level at
time t of the target protein p, bpq denotes the association
parameter of the q-th interactive protein to p-th target
protein, yq[t] represents the protein expression level of
the q-th regulator protein interacting with the target pro-
tein p, αp denotes the effect of translation from mRNA to
protein, xp[t] represents the mRNA expression level of
the corresponding target protein p, βp indicates the deg-
radation effect of the protein and ωp[t] is the stochastic
noise. The biological meaning of equation 1 is that the
protein expression of the target protein p at the next time
t+1 is contributed by the concentration of protein p at the
current time t, the effect of Q regulatory protein interac-
tions, the translation effect from mRNA, the degradation
effect of the present time, and some stochastic noises
[26].
Step 4
Association parameters in equation 1 were identified in
this step, and the model selection method Akaike Infor-
mation Criterion (AIC) was further used to prune the
rough PPAN according to the significance of the associa-
tion parameters. By solving the constrained least squares
parameter estimation problem and applying the most
parsimonious model order detection using the AIC algo-
rithm (see Supplementary Methods [Additional file 2]),
we sieved out the regulatory proteins that significantly
interact with the target protein on the genomic level, i.e.
among Q proteins in the rough PPAN, only Q' proteins
significantly interact with protein p. In other words, the
insignificant protein interactions or non-involved protein
association in this analytic time period could be deleted
by AIC. The pruning process was repeated one protein by
one protein. Consequently, the rough PPAN was pruned
to become the refined PPAN.
Cross-talk analysis by counting the CTRVs
To extract the significance from ever-changing associa-
tions and to determine if a protein is a possible cross-talk
candidate, an original approach based on catalogues of
pathway and dynamic associations in sequential time
stages was proposed to compute the Cross-Talk Ranking
Value (CTRV) for cross-talk analysis. We first clustered
every protein (node) in the network into different path-
ways, and then calculated the number of associations
which link outward to different pathways for each node.
The numbers of associations in different time stages were
summed up, resulting in the CTRVs. In general, if a pro-
tein has more associations to connect with several path-
ways, it would be considered to have more possibility as a
cross-talk candidate. It should be noted that the protein
associations, which link out as regulations to the other
proteins and link in as regulations from other protein, are
both important to the cross-talk analysis. A highly regu-
lated protein always plays a critical role to receive, medi-
ate or amplify signaling cascade, and a protein which
intensively regulates others is usually characterized as an
activator, inducer and transcription factor. Therefore, the
proposed measurement of CTRV concentrates on count-
ing the associations which link to different pathways for
each protein, rather than takes account of every linkage
as the ranking value, and the CTRVs of proteins are con-
sidered as a measurement to reflect the potential of a pro-
tein in connection with multiple signaling pathways. For
example, protein A belongs to pathway A, and protein B
belongs to pathway B. If all the proteins connected with
protein A are within the pathway A, the numbers of con-
nection for protein A will be considered as no change (see
Figure 3A). If protein A connects with protein B but they
belong to different pathways, then both ranking numbers
of protein A and B will be added by one (see Figure 3B).
Because the CTRVs are counted based on the pathway
catalogues, the way of pathway classification will be a
critical step to determine the values of CTRVs. There are
some proteins which have been proven to be involved in
more than one pathway, but it is not appropriate to assign
one protein to multiple pathway catalogues. The multi-
assignment will decrease the values of CTRVs, which may
cause the true cross-talk candidates to be neglected. To
overcome this problem, every protein is only assigned to
one pathway in this analysis. We assume that the active
sequence under the TNFα stress is TNFα, IL-1, MyD88-
dependent and finally MyD88-independent pathway. If
there is a protein involved in more than one pathway, this
protein will be assigned to the earliest activated pathway
among them. Because the realistic situation for the acti-
vated sequence of pathways in vivo is unavailable, this
y t y t b y t y t
x t
p p pq p q
q
Q
p p
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known knowledge. In other words, TNFα stress will
induce the gene expression and secretion of IL-1 cytokine
[27], and upon binding of IL-1, the IL-1 receptor will
associate with IL-1RAcP [28,29], forming a functional
signaling receptor complex to involve MyD88 to activate
the related pathway [30] Nevertheless, there is a lack of
evidence to reveal that the TNFα stimulus will induce the
MyD88-independent pathway, so we assume that this
pathway is activated last.
Results
Construction of refined PPANs at different time stages of 
inflammatory system
The proposed method was used to investigate the refined
PPANs at different time stages of inflammatory system
under TNFα stress. The genome-wide microarray data
downloaded from the Gene Expression Omnibus (GEO)
database at the NCBI website (http://
www.ncbi.nlm.nih.gov/geo/ accession number: GSE9055)
were adopted in this study. HUVEC (human umbilical
vein endothelial cells) were treated with 10 ng/ml TNFα
and the samples were collected every 15 or 30 minutes
(0~8 hrs, 25 time points) [31]. The data set of 25 time
points is divided into 6 time stages (0~1, 1~2, 2~3, 3~4,
4~6, 6~8 hr), resulting in 6 subsets of data. For each time
stage, the corresponding data is used to identify the
parameters in equation 1 and to prune down the rough
PPAN based on the identified parameters to obtain the
refined PPAN of each time stage, respectively. Conse-
quently, six refined PPANs are constructed for six time
stages. These refined PPANs are rearranged and visual-
ized by the Cytoscape tool [32] (see Figure 4). The num-
bers of nodes, edges and the highly connected hubs at
different time stages are shown in Table 2.
Investigation of the TNFα signaling network
TNFα is a highly pleiotropic cytokine of inflammation
that activates leukocytes and enhances adherence of neu-
trophils and monocytes to endothelium. As TNFα is syn-
thesized by macrophages and other cells in response to
pathogen-associated molecular patterns, inflammatory
products, and other invasive stimuli, it mediates cellular
responses through two distinct receptors, the p60 TNF
receptor (TNFR1, p55) and the p80 TNF receptor
(TNFR2, p75) [19]. These two receptors are present on
the plasma membranes of virtually all cells except the
erythrocyte, sharing structural homology in the extracel-
lular TNFα-binding domains and exhibiting similar bind-
ing affinity for TNFα. However, they induce separate
cytoplasmic signaling pathways following receptor-ligand
binding. In order to investigate the TNF pathway clearly,
TNFα-related proteins were extracted from the whole
network, and the TNFα-related pathway is shown in Fig-
ure 5A. The inferred functional modules supported by lit-
erature evidences in the refined PPAN are further shown
in Supplementary Table S2 [Additional file 3].
NFκB activation (TNFR1-TRADD-TRAF2-RIP) - One
major capability of TNFα signaling pathway is of mediat-
ing the activation of inflammatory response transcription
factor, NFκB. Upon activation of TNFR1 at the plasma
membrane, the TNFR1 death domain (DD) serves as a
docking site for the DD-containing adaptor protein
TRADD through homotypic DD interactions [33].
TRADD then sequentially recruits TNF receptor-associ-
ated factor 2 (TRAF2) and the serine/threonine kinase
RIP, which rapidly signals to NF-κB activation [33,34].
The functional module including proteins TNFR1,
TRADD, TRAF2, and RIP were successfully identified in
the PPAN.
Figure 3 Counting for the cross-talk ranking values (CTRVs). CTRV 
is a ranking value which reflects the potential of a protein in connec-
tion with multiple pathways. (A) All proteins connected with protein A 
belong to the same pathway A. In this case, the CTRV of protein A will 
not be changed. (B) If protein A connects with protein B, which be-
longs to a different pathway, then both CTRVs of protein A and B will 
be added by one.
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Figure 4 Refined PPANs for HUVEC under TNFα stress at different time stages. The illustration shows a time-series layout for each refined PPANs 
from 0 to 8 hour. Every refined PPAN is identified via a set of gene expression profile with five data points. In order to distinguish proteins involved in 
different signaling cascades, proteins belong to the same pathway are labeled with the same color. The progression of ever-changing associations 
obviously reveals that new connections continuously emerge, reflecting the fact that new signaling modules and function communities are involved 
in the endothelial inflammatory response to the TNFα stimulus. In addition, the top five hubs with highly connected degree are marked with larger 
font size. The numbers of nodes, edges and the highly connected hubs at different time stages are outlined in Table 2.
0~1 HR 1~2 HR
2~3 HR
4~6 HR 6~8 HR
3~4 HR
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Two other functional modules which associated with
NFκB activation were also recognized. TRAF5 has been
implicated in the TNF-induced NF-κB activation, as in
contrast to the single TRAF2 or TRAF5 knockout cells,
TRAF2/TRAF5 double-knockout cells show impaired
NF-κB activation upon TNF stimulation [35]. Unlike
TRAF2, TRAF5 only interacts with RIP, but not with
TRADD in co-immunoprecipitation assays [35], which
can also been seen in the PPAN. In addition, MEKK3 has
been shown to play a critical role in TNF-induced NF-κB
activation using MEKK3-deficient fibroblast cells [36].
MEKK3 was also demonstrated to directly phosphorylate
IKK and the kinase activity was regulated by TAK1
[36,37]. These functional interactions which result in NF-
κB activation are observed in the refined PPAN.
IKK activation (RIP-IKKs) and protein recruitment
(RIP-TAK1) - For the IKK activation, RIP responds to
TNF and becomes K63-poly-ubiquitinated at lysine 377
in its intermediate domain. This is indispensable for IKK
activation upon TNF stimulation, as mutation of lysine
377 abolishes the ability of RIP to rescue IKK activation
in RIP-deficient cells [38]. RIP also plays a role in the
recruitment of TAK1, as TAK1 fails to translocate to the
TNFR1 complex upon TNF stimulation of RIP-deficient
Jurkat cells [37].
Apoptosis (TRADD-RIP-FADD-TRAF2-CASP8) and
protein kinase (TAK1-TAB1-TAB2) - Apoptosis is
another critical function involved in the TNF pathway.
TNFα binding will promote the complex forming of
TNFR1 at the cell membrane. As TRADD, RIP and
TRAF2 dissociate from TNFR1, and endosomal TNFR1
recruits the DD-containing adaptor protein FADD, which
binds itself to caspase-8, a cytoplasmic complex forms
and is implicated in signaling to apoptosis [39]. Moreover,
the TAK1-TAB1-TAB2 complex is a protein kinase mod-
ule which takes part in the TNFα signaling transduction
and IKK activation. Activation of TAK1 leads to auto-
phosphorylation of TAB1, whereas TAB2 becomes phos-
phorylated at the membrane, probably by an upstream
protein kinase [40].
Investigation of the IL-1R and TLR-4 signaling networks
The IL-1R/TLR superfamily can be clustered into multi-
ple receptors, which all play a crucial role in both innate
and adaptive inflammatory systems [12]. Members of the
IL-1R subfamily are characterized by Ig-like domain that
binds to specific IL-1-related cytokines, which is a pri-
mary regulator of inflammatory and inflammatory
responses. By means of type I receptor (IL-1R1), it acti-
vates specific protein kinases, including the NFκB induc-
ing kinase (NIK) and three distinct mitogen-activated
protein (MAP) kinase cascades. These kinases modulate
a number of transcription factors including NFκB, AP1
and CREB, each of which regulates a plethora expression
of immediate early genes central to the inflammatory
response [41]. On the other hand, the TLR subfamily
includes 13 members that contain leucine-rich repeat
motifs in their extracellular domains, which recognize
distinct pathogen-associated patterns such as LPS,
microbial lipopeptides, viral double-stranded RNA and
CpG DNA [42]. These receptors have been established to
play an essential role in the activation of inflammation
and induce the release of critical pro-inflammatory
cytokines that are necessary to activate potent inflamma-
tory responses [43]. The cytoplasmic portions of both
IL1R- and TLR-family members share a common struc-
tural motif, the so-called TLR and IL-1R (TIR) homology
domain at their cytoplasmic portion [44]. Like TNFRs,
TIR-containing receptors do not have catalytic activity
and use intracellular adaptors and signal-transducing
molecules to activate effector pathways [45]. Homotypic
TIR-TIR interactions with a limited set of TIR-containing
adaptors explain why more than 15 different receptors
trigger only a small number of signaling pathways [45].
Because of the largely common use of signaling modules,
the IL1R- and TLR4-related pathways were integrated
into the same diagram for investigation (see Figure 5B).
The inferred functional modules supported by literature
Table 2: Statistics of the TNFα-induced protein-protein association networks of HUVEC.
Duration Nodes Edges Highly connected proteins
0~1HR 56 144 TRAF2 IRAK1 TRAF6 IKKα IKKβ
1~2HR 56 156 TRAF2 TRAF6 IRAK1 RIP TNFR1
2~3HR 56 150 IRAK1 TRAF6 TRAF2 IKKα RIP
3~4HR 55 152 TRAF2 IKKα TNFR1 IRAK1 TRAF6
4~6HR 56 151 IRAK1 TRAF2 TRAF6 RIP TNFR1
6~8HR 56 156 TRAF2 TRAF6 RIP IKKα IRAK1
Summary of the reconstruction of protein-protein association networks at different time stages. Proteins with maximal protein-protein 
associations are sorted in this table. These proteins are usually considered as the hubs which will be involved in several biological functions 
and play important roles in the signaling network.
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Figure 5 Investigations of the (A) TNFα-related pathway and (B) IL-1/TLR4-related pathways. Protein components which are ultimately respon-
sible for the trigger of an inflammatory function are labeled with the same color in the pathway, and the thicker red edges represent the associations 
listed in Supplementary Table S2 [Additional file 3] and Supplementary Table S3 [Additional file 4].
Proliferation Apoptosis p38 MAPK NFkB
(A)
(B)
Apoptosis NFkB Type I infection
RIP
TIRAP
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Page 11 of 19evidences in the refined PPAN are further shown in Sup-
plementary Table S3 [Additional file 4].
Pathway adaptor (MyD88-TLR4-IL1, IL1-IL1R1-
MyD88-TOLLIP-IRAK1) - MyD88 is the universal adap-
tor for TLRs and is also a member of the IL-1 receptor
subfamily [30]. Upon binding of IL-1, the IL-1R1 will
associate with IL-1 receptor accessory protein (IL-
1RAcP), forming a functional signaling receptor complex
[28]. Then TIR domain containing adaptor protein
MyD88 is recruited to the receptor complex [29]. This
leads to the translocation of IRAK1, together with the
adaptor protein TOLLIP [46], into the IL-1R1 and then
IRAK1 interacts with TRAF6 [47]. The functional mod-
ules which are responsible for adaptation are observed in
the refined PPAN.
Protein kinase (TRAF6-IRAK1-IRAK4, TRAF6-
IRAK1-TAK1-TAB1-TAB2) and IKK activation (TRAF6-
IKKs) - After forming the pathway adaptor modules,
IRAK4 is recruited to TRAF6 and activated by intramo-
lecular autophosphorylation [48]. Activation of IRAK4
leads to phosphorylation of IRAK1, procuring full kinase
activity [48,49]. Then the IRAK-1-TRAF6 complex inter-
acts with a pre-existing TAK1-TAB1-TAB2 membrane-
bound complex [50], thus forming the protein kinase
module. After that, the protein kinase module will trans-
locate to the cytosol, whereas IRAK1 stays at the mem-
brane and becomes polyubiquitinated. In the cytoplasm,
TRAF6 interacts with the E2 ubiquitin-conjugating
enzyme complex Ubc13/Uev1A [51]. In addition, lysine
124 in TRAF6 was identified as the main ubiquitin accep-
tor site for autoubiquitination, and mutation of this lysine
leads to impaired TAK1, IKK and JNK activation [52,53].
Oligomerization of TRAF6 might lead to auto-polyubiq-
uitination of TRAF6, which is necessary for IL-1-and
LPS-induced NF-κB activation, whereas TRAF6- induced
poly-ubiquitination of NEMO (NF-κB essential modula-
tor) might rather play a role in IL-1-induced JNK activa-
tion [12].
Cross-talk analysis of the refined PPANs
Our analyses have demonstrated many protein associa-
tions that showed characteristics of a real inflammatory
system in the refined TNFα, IL-1, and TLR4 PPANs. To
further understand the dynamic properties of hubs and
cross-talks between different signaling pathways in the
refined PPANs, we counted the CTRVs of each protein
for cross-talk analysis of the refined PPANS. Proteins in
this cross-talk analysis were classified into four major
pathways, including TNFα, IL-1, MyD88-dependent and
MyD88-independent pathways. In addition, negative reg-
ulators may also be important factors to be taken into
consideration in this analysis because the cell responses
must be stringently regulated. Exaggerated expression of
signaling components and pro-inflammatory cytokines
may cause devastating effects on the host. The negative
regulators can act at multiple levels within inflammatory
signaling cascades, as well as can elicit negative feedback
mechanisms to synchronize the positive activation and
negative regulation of signal transduction to avert poten-
tially harmful consequences [23]. The results of the cross-
talk analysis are shown in Table 3 and Table 4. In Table 3,
the CTRVs and link values, which indicated the total
numbers of association for each node at six different time
stages, were listed for all 60 proteins. The contrast
between link and CTRVs (for example, CASP8) reflected
that not all proteins with high connective degree in the
refined PPAN would also be with high CTRVs. In Table 4,
proteins with high CTRVs at different time stages are pre-
sented. From Table 2 and Table 4, we found that some
proteins with high CTRVs at different time stages such as
NIK and A20 were not ranked top according to node
degree, revealing that our proposed method generated
new insights into the evaluation of cross-talk candidates.
The biological significance of some highly ranked pro-
teins we identified (Table 3) was investigated. Interleukin-
1 receptor-activated kinase 1 (IRAK1, ranked No.1) is one
of the key mediators in the signaling pathways of TLRs/
IL-1Rs. IRAKs which initiate a cascade of signaling
events eventually lead to induction of inflammatory tar-
get gene expression [54]. IRAK1 activation constitutes an
important signaling module in both IL-1R and TLR signal
transductions. Binding to myeloid differentiation primary
response protein (MyD88, ranked No.5) brings IRAK1
and IRAK4 together at the receptor complex and facili-
tates the phosphorylation of IRAK1. In the downstream
of MyD88, the important role of IRAK and TRAF6 in
related pathways has also been confirmed in some knock-
out studies. Cells from IRAK-deficient mice were shown
to be defective in their response to IL-1 and IL-18 [55].
Tumor necrosis factor receptor-associated factor 6
(TRAF6, ranked No.2) is a pivot signaling molecule regu-
lating a diverse array of physiological processes including
adaptive immunity, innate immunity and the develop-
ment of several tissues. It is also essential for the signaling
downstream of the IL-1R/TLR superfamily [56]. The cru-
cial biological role of TRAF6 in the IL-1R/TLR signaling
has been demonstrated by the targeted deletion of
TRAF6 [57,58]. Mitogen-activated protein kinase kinase
kinase 14 (NIK, ranked No.3) is a member of the MAP-
KKK family that may either directly or indirectly phos-
phorylate or activate IKKα/β, leading to the
phosphorylation and degradation of IκBα followed by
NFκB activation [59]. NIK is also a common mediator of
NF-κB activation by the TNF receptor family and shown
to activate the downstream of TRAF-associating receptor
signaling pathways, including TNFR, CD40, CD30 and
LTβr [60,61]. Tumor necrosis factor, alpha-induced pro-
tein 3 (TNFAIP3/A20, ranked No.4) is a protein which
Yang et al. BMC Medical Genomics 2010, 3:19
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stimuli [62]. Although A20 was originally characterized
as an inhibitor of TNF-induced apoptosis [63], it has been
most intensively studied as an inhibitor of NF-κB activa-
tion. The use of A20-deficient mice and RNA interfer-
ence technologies has revealed the crucial role of A20 in a
variety of pathogen- and cytokine-induced signaling
pathways. Mice lacking A20 are born at normal Mende-
lian ratios but die shortly after birth due to massive multi-
organ inflammation, which is an indication of a key role
for A20 in homeostasis of the host [64].
Although there are still many highly ranked proteins
with critical roles in signal transduction like MyD88 and
SIGIRR, it is not our intension to use an exhaustive attack
method to prove them one by one. Instead, the global
properties and robustness of the network architecture in
the sequel will be investigated.
Discussion
In this study, the rough PPANs are constructed at first
based on the selected proteins of interest and the data-
base information of protein-protein interactions. We
Table 3: Cross-talk ranking values (CTRVs) and link values of significant proteins in PPAN.
No. Protein CTRV Link No. Protein CTRV Link
1 IRAK1 108 140 31 IL1R1 21 21
2 TRAF6 83 124 32 FADD 19 55
3 NIK 77 89 33 GRB2 18 46
4 A20 61 61 34 TAK1 17 66
5 MYD88 59 107 35 SOCS1 17 17
6 TRAF2 58 198 36 TRIF 16 54
7 IKKα 55 83 37 TMED1 12 12
8 SIGIRR 53 73 38 CASP8 10 87
9 TLR4 53 53 39 TAB2 10 53
10 IKKγ 52 84 40 CAV1 10 44
11 IKKβ 47 97 41 TAB1 9 44
12 BCL10 43 62 42 TTRAP 8 8
13 UBE2N 41 41 43 ECSIT 8 50
14 IRAK4 38 112 44 CYLD 6 6
15 RIP 38 57 45 TNF 0 48
16 TRAF3 37 57 46 TNFR2 0 39
17 IRAK3 36 36 47 IKKε 0 29
18 ST2L 32 32 48 PELI2 0 19
19 TNIP3 32 32 49 IL1B 0 18
20 PTPN11 31 31 50 MEKK3 0 18
21 TIRAP 29 40 51 TRAM 0 18
22 TRAF4 27 27 52 IL1A 0 17
23 TOLLIP 26 47 53 IL1R2 0 17
24 RNF216 25 25 54 TRAF5 0 17
25 TNFR1 24 111 55 SOS1 0 10
26 RIP3 23 93 56 IRF3 0 9
27 TRADD 23 32 57 NOD2 0 0
28 TBK1 22 39 58 CD14 0 0
29 PELI1 21 49 59 SARM1 0 0
30 TANK 21 40 60 FLN29 0 0
To integrate the information from the complex PPANs, the cross-talk ranking values (CTRVs) at different time stages are summed up for each 
protein. In contrast with CTRVs, the values of link represent the total number of protein-protein associations at six time stages of each protein. 
It reveals that not all nodes with high connective degree will also have high CTRVs such as CASP8.
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tionship between the target protein and the proteins pos-
sibly interacting with it in the rough PPAN. For each
protein in the rough PPAN, the possible interactions are
established via equation 1. Next, with the help of
microarray data, the parameters in equation 1 are identi-
fied using the constrained least squares estimation
method, i.e. every interaction should be confirmed by the
real microarray data. Finally, the Akaike Information Cri-
terion (AIC) is used to determine the insignificant bpq's in
equation 1, thus pruning the initial rough PPAN into the
refined PPAN by detecting the insignificant interactions.
The data set of 25 time points we used is divided into six
time stages, and six refined PPANs are constructed based
on these six subsets of data. Some dynamic characteris-
tics and structures of the reconstructed PPANs of inflam-
mation are discussed in the following.
Dynamic progression of the PPANs
To determine the dynamic progression of PPANs at dif-
ferent time stages, we presented the time series PPANs
from 0 to 3 hours in which the positions of nodes are
rearranged based on approximately up/down-stream
relations (see Figure 6, and the complete and pellucid
time series diagrams from 0 to 8 hours are presented in
Supplementary Figures [Additional file 5]).
In the first hour, there is a very obvious signal cascade
which passes through TNFR1, TRADD, TRAF2, RIP,
NIK, TAK1/TAB1/TAB2 complex and finally reaches the
IKK complex (see Figure 6, 0~1 hour, red edges). It seems
to be the rapidest way to activate the NF-κB transcription
by TNFα induction. This well-characterized pathway
contains NF-κB, JNK, p42/p44 mitogen-activated protein
kinase (MAPK) and p38 MAPK [19]. Interestingly, NIK,
which seems to be an important mediator between RIP
and IKK family in our network diagram, was not previ-
ously considered to be a part of the TNF-induced NF-κB
activation. However, Yin et al. found that NIK is required
for NF-κB activation by LTβR [65]. In addition, MAP/
ERK kinase kinase kinase 3 (MEKK3) is also involved in
this pathway by RIP. Gene deletion studies have indicated
that MEKK3 is required for IKK activation and functions
downstream of RIP in TNF-induced NF-κB activation
[66]. In the second hour, the IL-1R/TLR4 signaling path-
ways are sequentially turned on after the TNFR-related
pathway (see Figure 6, 1~2 hour, red edges). This obser-
vation suggests the movement of autocrine signaling, in
which a cell secretes a hormone or chemical messenger
that binds to autocrine receptors on the same cell type,
leading to changes in the cells. At this time point, the
connections in the TNFR pathway become relatively less
than those shown in the first hour and even display an
inhibitory effect on this pathway. The reason for the rear-
rangement of protein associations might be that the cell's
inflammatory mechanism tends to focus on some specific
mechanisms which largely share common community to
fight against the pathogens, rather than distributes
resources to the overextended pathways. In the third
hour, the TNFR-related pathway is triggered again. It is
noticed that several negative regulators such as SOC1
(inhibitor of TIRAP (MAL) and p56), IRAK3 (inhibitor of
IRAK1 and IRAK4) and A20 (inhibitor of TRAF6) are sig-
nificantly expressed at this stage, reflecting the inhibitory
effect of anti-inflammation (see Figure 6, 2~3 hour, pur-
ple edges). Apart from these three refined PPANs, the
dynamic properties of another three residual networks of
the late stages of immunity (3 to 4, 4 to 6 and 6 to 8 hours)
are more like at steady state without significant perturba-
tions (see Supplementary Figures [Additional file 5]).
Specific architecture in the signaling network
A cell's behavior is a consequence of the complex interac-
tions between its numerous constituents, such as DNA,
RNA, proteins and small molecules. Cells use signaling
pathways and regulatory mechanisms to coordinate mul-
tiple processes, allowing them to respond and adapt to an
ever-changing environment. In case of pathogen invad-
ing, the human inflammatory system is required to rap-
Table 4: Proteins with high cross-talk ranking values at different time stages.
Duration Top ranked proteins
0~1HR IRAK1 NIK IKKα TRAF6 IKKβ
1~2HR TRAF6 IRAK1 NIK A20 TRAF2
2~3HR IRAK1 TRAF6 NIK A20 TRAF2
3~4HR IRAK1 NIK TRAF6 A20 IKKγ
4~6HR IRAK1 TRAF6 NIK TRAF2 A20
6~8HR IRAK1 NIK TRAF6 IKKα A20
In contract with Table 2, proteins with maximal CTRVs are listed here. Among these highly ranked proteins, NIK and A20 are considered as 
two core elements in the signaling network by the analysis of CTRV, but their importance is not exhibited in Table 2. This reveals that our 
proposed method generates a new insight into the evaluation of cross-talk candidates.
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Figure 6 Dynamic progression of refined PPANs for HUVEC under TNFα stress. Time series refined PPANs under the TNFα stress from 0 to 3 hours 
are presented to monitor the dynamic properties of association progression. Positions of nodes are rearranged based on approximately up/down-
stream relationships of the proteins. The general signaling proteins are shown as elliptic nodes; square nodes represent the receptor proteins and 
diamond nodes represent the possible negative regulator proteins. Dash gray lines represent the associations which are related to negative regulators. 
The levels of gene expression are indicated by the node color, in which the red color means the gene expression at that time is higher than its gene 
expression without TNFα treatment and the green color means the gene expression at that time is lower than its gene expression without TNFα treat-
ment. The complete and pellucid time series diagrams from 0 to 8 hours are presented in Supplementary Figures [Additional file 5].
0 ~ 1 Hour
1 ~ 2 Hour
2 ~ 3 Hour
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the lethal factors without unnecessary wastage. Figure 7
displays the bow-tie structure extracted from the PPANs.
The core elements in the bow-tie structure are the highly
ranked proteins according to the CTRV ranking algo-
rithm. As different receptors on the cell membrane are
only able to recognize their specific pathogen-associated
molecular patterns (PAMPs), these receptors need to
form various functional modules by complex and dimer/
trimer assembling for representing different signals of
pathogens. Then these various types of signal would con-
verge to a common cross-talk, that is, the core elements
in the bow-tie structure. Therefore, the cross-talks may
be considered as a robust and efficient signal processor
on the pivotal position of signal transduction, which plays
a role of rearranging the sinew and determines which
necessary protective mechanisms or recruitments should
be activated. Through the coordination of signal proces-
sor, inflammatory system organizes the order and balance
in the cell and human body.
Oda and Kitano manually integrated 411 published lit-
eratures and presented a comprehensive map of TLRs
and IL-1 receptor signaling networks under different
stimulant conditions [67]. This map illustrates the possi-
ble existence of a main network subsystem that has a
bow-tie structure in which MyD88 is a non-redundant
core element, two collateral subsystems with small
GTPase and phosphatidylinositol signaling, and MyD88-
independent pathway [67]. In comparison of our ranking
results with their signaling map, it reveals that the top
ranked proteins such as IRAK1 (ranked No.1), TRAF6
(ranked No.2) and MyD88 (ranked No.5) in our study
have also been considered the pivotal roles in the bow-tie
core process. Specifically, the process mediates various
types of stimulant signals and triggers the downstream
activation of NF-κB and MAPK cascade, leading to the
induction of many target genes such as cytokines. How-
ever, the map of Oda and Kitano only reflects the possible
static connections without stimulus-specific response or
temporal changes. In contrast, we integrated the gene
expression patterns from time course data to infer the
dynamic protein-protein interactions and networks.
Consequently, our results may suggest a more significant
and realistic bow-tie core network under a specific stimu-
lus.
Possible existence of TLR4 endogenous ligand
Though the main focus of our study is the TNFRs that are
different from the TLRs in Oda and Kitano [67], numer-
ous similar functional modules are identified in this
study. This observation reveals the characteristics of
module community in the inflammatory system and the
presence of active feedback signals from cytokines. It is
proven that TNFα-induced cells will activate the tran-
scriptional expression of several genes encode cytokines
such as IL-1α, IL-1β and IL-6 [27]. These autocrine sig-
nals can act as the positive feedback to enhance the
inflammatory responses by turning on other correlated
inflammatory pathways, such as IL-1 and MyD88-depen-
dent pathway of TLR4. Interestingly, in addition to the
two pathways mentioned above, our TNFα-induced
HUVEC model also exhibits the virtually complete acti-
vation of MyD88-independent pathway of TLR4 which
theoretically may not be involved in the single TNFα-
treated condition (see Figure 5B). It has been shown that
increased expression and signaling by TLR4 may contrib-
ute to the activation of innate immunity in the injured
myocardium [68]. Because no infection is evident in this
model, our observation raises the intriguing possibility
that TLR4 may also function during inflammation, possi-
bly in response to an endogenous ligand. One candidate
of this ligand is S100, a multigenic family of non-ubiqui-
tous Ca2+-modulated proteins of the EF-hand type
expressed in vertebrates exclusively [69]. It has been dem-
onstrated that primary tumors secrete soluble factors,
including VEGF-A, TGFβ and TNFα, which induce
expression of S100 in the myeloid and endothelial cells
within the lung prior to tumor metastasis [70]. Recently,
the increased S100A8 and S100A9 levels were also
detected in various human cancers, presenting abundant
expression in neoplastic tumor cells as well as infiltrating
immune cells [71]. Its expression and potential cytokine-
like function in inflammation and in cancer suggests that
S100A8/A9 may play a key role in inflammation-associ-
ated cancer. Another candidate is high-mobility group
box 1 (HMGB1), which is one kind of damage-associated
molecular patterns (DAMPs). HMGB1 is a nuclear pro-
tein expressed in nearly all cell types. In normal condi-
tions, HMGB1 binds to DNA and facilitates gene
transcription. Under stress conditions such as injury and
infection, HMGB1 is released and promotes inflamma-
tion [72]. TLR4 has been identified as a receptor of
HMGB1 as well as TLR2 and RAGE (receptor of advance
glycation end product) [73]. As the mechanisms of pro-
moting the release of HMGB1 and its activating signaling
pathways remain to be completely elucidated, HMGB1
also appears to have several regenerative effects leading
to tissue repair [72,74]. Therefore, HMGB1 has potential
significance in clinical medicine.
Negative feedback controls of the cross-talks
Inflammation is normally a protective response to
destroy, dilute, or isolate an eliciting agent and to pro-
mote the repair of injured tissue. However, when inflam-
mation is excessive or persistent, it may cause tissue
injury or organ dysfunction and may contribute to the
pathogenesis of disease. For this reason, at the anti-
inflammation stage cells need to make use of the negative
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some dominant cross-talks to recover from the dramatic
activations in inflammation. This kind of negative feed-
back has also been proven to be related to some TNFα-
mediated inflammatory diseases. For example, A20 has
been identified as a negative regulator of the core cross-
talk element TRAF6 [75], and several studies have shown
that deficiencies in A20 are associated with some autoim-
mune diseases, including rheumatoid arthritis [76], sys-
temic lupus erythematosus [77], and Crohn's disease [78].
These clues also reveal the fragility of the bow-tie struc-
ture. Because of the non-redundant property of core ele-
ments in the bow-tie structure, some targeted
Figure 7 Bow-tie structure under TNFα stress for multiple pathways in the inflammatory system. A specific architecture of TNFα-induced en-
dothelial inflammatory system is extracted from the PPAN in which the core elements of the bow-tie structure are identified via the CTRV ranking al-
gorithm. Upon ligand binding, various types of receptors on the cell membrane trigger different signaling pathways and activate the downstream 
corresponding transcription factors such as NFκB. NFκB then regulates the expression of genes involved in inflammatory responses. These kinds of 
gene expression will induce some particular biological mechanisms helping the host to defense the invading microorganisms. In addition, the trans-
lation of cytokines and some negatively regulatory proteins will play roles of feedback control to coordinate the balance in immunity.
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Page 17 of 19perturbations from environment and lethal pathogens
might result in destructive consequences.
On the other hand, negative feedback controls may also
play an important role to buffer the wide range of envi-
ronment stimuli. Previous studies have indicated that
proteasome inhibition can suppress TNFα-induced acti-
vation of adhesion molecules in endothelial cells in vitro
[79,80]. These studies showed that short-term treatment
of endothelial cells with high doses of proteasome inhibi-
tors results in strong inhibition of cytokine-induced
expression by preventing nuclear translocation of NF-κB.
Cheong et al. undertook an iterative computational and
experimental investigation of the dynamic properties of
TNFα-mediated activation of the transcription factor
NF-κB [81]. They found that the temporal profile of the
NF-κB activity is invariant to the TNFα dose from 0.1 to
10 ng/ml. These discoveries reflect the properties of
robustness and protective mechanisms in the inflamma-
tory system which might also be the effects of feedback
controls to the cross-talks in the signaling network. As
the environmental stresses trigger the appropriate
responses to protect organisms themselves, it will help
their survival. However, if the stresses suddenly perturb
to an acute level and the inflammatory responses still take
a correspondingly sharp response to excessively activate
the downstream reactions, the protective mechanisms
will instead injure the organisms. For this reason, there
must be some cross-talks which buffer the perturbation
from upstream signals and respond to the downstream
negative feedback regulators to alleviate the reflecting
scale.
Conclusions
In this study we attempt to integrate protein-protein
interactions from databases and gene expression profiles
of TNFα-induced HUVEC to construct the protein-pro-
tein association networks (PPANs) at different time
stages to illustrate the development of an endothelial
inflammatory system. A new cross-talk ranking method
is suggested to evaluate the potential core elements in the
related signaling pathways of toll-like receptor 4 (TLR-4)
as well as receptors for tumor necrosis factor (TNF-R)
and interleukin-1 (IL-1R). The highly ranked cross-talks
which are functionally relevant to the TNFα stress are
also identified. A bow-tie structure is then extracted from
these cross-talk pathways for the robustness of network
structure, the coordination of signal transduction and the
feedback control for efficient inflammatory responses to
different stimuli. Further, several characteristics such as
possible existence of TLR4 endogenous ligand and the
effects of negative feedback control to the cross-talks are
discussed.
A systematic approach based on stochastic dynamic
model is proposed for biologists to generate insight into
the underlying defense mechanisms of endothelial
inflammatory systems via the construction of corre-
sponding signaling networks upon specific stimulus. The
dynamic model provides a mathematical regulatory
mechanism of the biological networks, resulting in not
only qualitative but also quantitative dynamic character-
ization. This model can also be integrated with the down-
stream signaling networks such as PPAN of NFκB and
gene regulatory networks [82] to investigate more com-
prehensive issues. Further, based on the dynamic model,
we can also discuss the robust stability and noise filtering
ability of the biological network against the intrinsic fluc-
tuation and environmental disturbances [83]. In addition,
this systematic approach can be applied to other signaling
networks under different conditions in different species.
As better experimental techniques for protein expression
detection and microarray data with multiple sampling
points become available in the future, the performance of
the proposed method will be much improved and the
dynamic PPANs under different conditions can be com-
pared extensively.
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